Kyivmedpreparat Logo

Kyivmedpreparat

Pharmaceutical manufacturer specializing in antibacterial, generic, and original drugs.

KMED | Ukrainian Stock Exchange

Overview

Corporate Details

ISIN(s):
UA4000106140
LEI:
Country:
Ukraine
Address:
139 Saksaganskogo Str., 01032 Kyiv

Description

Kyivmedpreparat is a pharmaceutical manufacturer specializing in the production of antibacterial drugs. The company is a leading producer in this segment and also manufactures a broad portfolio of generic and original medicines. Its products are available in various dosage forms, including injectables. As part of the Arterium Corporation, the company is focused on developing and providing high-quality, patient-centric medicinal solutions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Kyivmedpreparat filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kyivmedpreparat

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kyivmedpreparat via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Modalis Therapeutics Corporation Logo
Develops genetic medicines using a proprietary epigenome editing technology.
Japan
4883
Moderna, Inc. Logo
Biotechnology company developing messenger RNA (mRNA) therapeutics and vaccines.
United States of America
MRNA
Molecular Partners AG Logo
Clinical-stage company developing novel protein therapeutics for oncology.
Switzerland
MOLN
Moleculin Biotech, Inc. Logo
A late-stage pharmaceutical company developing drugs for resistant cancers and viruses.
United States of America
MBRX
Monte Rosa Therapeutics, Inc. Logo
Develops molecular glue degraders to eliminate disease-causing proteins.
United States of America
GLUE
Develops nanomedicine-based drug delivery systems for treating severe diseases.
South Korea
322970
MoonLake Immunotherapeutics Logo
Clinical-stage biopharma developing Nanobody therapies for inflammatory diseases.
United States of America
MLTX
MORISHITA JINTAN CO.,LTD. Logo
Healthcare firm making supplements and pharma with patented seamless capsule technology.
Japan
4524
MorphoSys AG Logo
Biopharmaceutical company developing antibody-based medicines for cancer patients.
Germany
MOR
MUSTANG BIO, INC. Logo
Clinical-stage biopharma developing cell and gene therapies for cancer and rare diseases.
United States of America
MBIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.